AI assistant
Sending…
NANOVIRICIDES, INC. — Director's Dealing 2009
Jun 16, 2009
34915_dirs_2009-06-16_060a9f80-dc55-46ab-bab9-d20c6c124505.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: NANOVIRICIDES, INC. (NNVC.OB)
CIK: 0001379006
Period of Report: 2009-06-12
Reporting Person: Theracour Pharma, Inc. (10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2009-06-12 | Common Stock | S | 7000 | $.60 | Disposed | 34764500 | Direct |
Footnotes
F1: Represents shares of common stock sold in accordance with TheraCour's Rule 10b5-1 Trading Plan adopted with the Registrant as disclosed on Form 8-K on February 10, 2009.
More from NANOVIRICIDES, INC.
Regulatory Filings
2026
May 21
Regulatory Filings
2026
May 20
Regulatory Filings
2026
May 18
Interim / Quarterly Report
2026
May 14
Interim / Quarterly Report
2026
Feb 17
Capital/Financing Update
2025
Dec 30
Regulatory Filings
2025
Dec 22
Regulatory Filings
2025
Dec 16
Capital/Financing Update
2025
Dec 15
Declaration of Voting Results & Voting Rights Announcements
2025
Nov 26